U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Finemost Corporation - Close Out Letter 2/15/18
  1. Compliance Actions and Activities

CLOSEOUT LETTER

Finemost Corporation Feb 15, 2018

Finemost Corporation - Close Out Letter 2/15/18


Recipient:
Finemost Corporation


United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

 

 
Office of Human and Animal Foods Division West 5
Los Angeles District Office
19701 Fairchild, Irvine CA
Telephone: 949-608-2900
Fax: 949-608-4417 

UNITED PARCEL SERVICE
SIGNATURE REQUIRED

February 15, 2018

Mr. Samuel S. Chang, CEO
Finemost Corporation
13839 Bentley Place
Cerritos, CA 90703

Dear Mr. Chang:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter [WL#32-13 issued March 20, 2013]. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Darla Bracy, District Director
Office of Human and Animal Food
Division 5 West